Stock Markets March 18, 2026

FAA Clears Boeing 777-9 to Enter Fourth Certification Phase, Sources Say

Boeing has secured approval for the third certification stage and is now permitted to advance the 777-9 into phase four, while two further approvals remain outstanding

By Nina Shah BA
FAA Clears Boeing 777-9 to Enter Fourth Certification Phase, Sources Say
BA

Federal aviation authorities have allowed Boeing to move its 777-9 jet into the fourth stage of certification testing, according to people familiar with the matter. The development follows CFO Jay Malave's statement that approval for the third stage had been secured; two more approvals are still required. The 777-9 is the initial variant of Boeing's delayed 777X program, which has incurred $15 billion in development charges and is six years behind schedule.

Key Points

  • FAA permission allows the 777-9 to begin the fourth phase of certification testing; this follows approval of the third phase reported by Boeing's CFO.
  • Boeings 777-9 is the initial model of the 777X family, which succeeds the 747 and earlier 777 and, together with the 787 Dreamliner, forms the companys widebody long-haul lineup.
  • The 777X development program has generated $15 billion in charges and is reported to be six years behind schedule, highlighting financial and execution pressures on Boeing and its suppliers.

Federal aviation authorities have permitted Boeing to proceed with the next step of certification for its 777-9 jet, according to people familiar with the matter. That clearance allows the 777-9 to enter the fourth stage of testing, marking another procedural milestone in a program that has experienced repeated delays.

The announcement follows comments by Boeing's chief financial officer, who said at an investor conference that the company had already secured approval for the third certification phase. At the conference the CFO noted that there remain two additional stages of approval to obtain, and that the company was awaiting the next one "very shortly here."

"There are two more that we need to get approval for, and we9re waiting for the next one very shortly here," Malave said.

The 777-9 is the first model in Boeing's 777X family. The 777X program represents the successor to the 747 and the earlier 777 series and, together with the 787 Dreamliner, constitutes Boeing's widebody offering for long-haul commercial air travel.

Boeing has already recorded $15 billion in charges against the 777X development program. The company has characterized the program as running six years behind its original timetable. Those write-downs and the extended schedule have been prominent features of the program's financial profile.

From a market and sector perspective, the development touches aerospace manufacturing and the commercial airline fleet cycle, since the 777-9 is positioned within Boeing's long-haul widebody product set. Investors and market participants remain attentive to the remaining certification steps, given the program's history of delays and the magnitude of charges booked to date.


Context and next steps

The immediate development is a procedural clearance to begin the fourth certification phase. According to the CFO's remarks, Boeing has two further certification approvals to secure after the current step. The timing and outcome of those remaining approvals were not detailed by company representatives or the sources cited.

Risks

  • Additional certification approvals are still required - failure to obtain them would delay entry into service and affect aerospace manufacturing and airline fleet planning.
  • The 777X program has already resulted in $15 billion of development charges, indicating financial strain; further cost increases or delays could influence Boeings financial results and capital allocation decisions.
  • The program remains six years behind schedule, introducing ongoing execution risk for Boeing and potential downstream impacts on airlines awaiting widebody deliveries.

More from Stock Markets

Zillow Shares Tick Higher After Compass Drops Antitrust Lawsuit Mar 18, 2026 UK to Boost Military Aid and Missile Stocks for Gulf Partners Amid Iranian Drone Attacks Mar 18, 2026 Analysis: TrumpRx prices not uniformly below U.K. levels, Reuters comparison finds Mar 18, 2026 Unilever Shares Drop as Investors Worry Food Unit Split Could Distract Management Mar 18, 2026 Figma Shares Slide After Google Labs Expands Stitch AI Design Tool Mar 18, 2026